↓ Skip to main content

Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn’s Disease

Overview of attention for article published in Frontiers in Pharmacology, May 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn’s Disease
Published in
Frontiers in Pharmacology, May 2021
DOI 10.3389/fphar.2021.658087
Pubmed ID
Authors

Qianqian Li, Xiao Ding, Yujie Liu, Cicilia Marcella, Min Dai, Ting Zhang, Jianling Bai, Liyuan Xiang, Quan Wen, Bota Cui, Faming Zhang

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 20%
Student > Master 2 10%
Other 1 5%
Student > Doctoral Student 1 5%
Professor > Associate Professor 1 5%
Other 1 5%
Unknown 10 50%
Readers by discipline Count As %
Medicine and Dentistry 4 20%
Arts and Humanities 1 5%
Nursing and Health Professions 1 5%
Immunology and Microbiology 1 5%
Computer Science 1 5%
Other 2 10%
Unknown 10 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2022.
All research outputs
#14,918,951
of 25,874,560 outputs
Outputs from Frontiers in Pharmacology
#4,612
of 20,034 outputs
Outputs of similar age
#209,525
of 458,964 outputs
Outputs of similar age from Frontiers in Pharmacology
#237
of 972 outputs
Altmetric has tracked 25,874,560 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,034 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,964 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 972 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.